Corresponding anaplastic lymphoma kinase–tropomyosin 3 (ALK-TPM3) fusion in a patient with a primary cutaneous anaplastic large-cell lymphoma and a Spitz nevus
Open Access
- 1 November 2019
- journal article
- Published by Elsevier in JAAD Case Reports
- Vol. 5 (11) , 970-972
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomasBlood, 2019
- Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives (Review)Oncology Letters, 2018
- FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case reportHuman Pathology, 2018
- Kinase fusions are frequent in Spitz tumours and spitzoid melanomasNature Communications, 2014
- Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.2000
- Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatmentBlood, 2000
- A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.1999
- A New Fusion Gene TPM3-ALK in Anaplastic Large Cell Lymphoma Created by a (1;2)(q25;p23) TranslocationBlood, 1999